Skip to content
10-Q

Quarterly Report

XBIOTECH INC. XBIT

0001171843-24-004689

← back to feed
Filed
Aug 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 12, 2024 30.46M sh
Stock Repurchased Q2 2024 · Jun 30, 2024 $0
Stock Repurchased Q2 2024 · Jun 30, 2023 $14K
Cash And Equivalents Q2 2024 · Jun 30, 2024 $188.53M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $200.02M
Current Liabilities Q2 2024 · Jun 30, 2024 $17.14M
Current Liabilities Q2 2024 · Dec 31, 2023 $6.1M
Total Liabilities Q2 2024 · Jun 30, 2024 $18.85M
Total Liabilities Q2 2024 · Dec 31, 2023 $7.77M
Current Assets Q2 2024 · Jun 30, 2024 $190.64M
Current Assets Q2 2024 · Dec 31, 2023 $201.72M
Total Assets Q2 2024 · Jun 30, 2024 $215.56M
Total Assets Q2 2024 · Dec 31, 2023 $226.62M
Capex Q2 2024 · Jun 30, 2023 $214K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$13.81M
Stockholders Equity Q2 2024 · Jun 30, 2023 $229.06M
Stockholders Equity Q2 2024 · Mar 31, 2023 $236.91M
Stockholders Equity Q2 2024 · Dec 31, 2022 $240.4M
Eps Basic Q2 2024 · Jun 30, 2023 −$0.29
Eps Basic Q2 2024 · Jun 30, 2023 −$0.41
Sga Expense Q2 2024 · Jun 30, 2023 $1.99M
Sga Expense Q2 2024 · Jun 30, 2023 $2.91M
Rd Expense Q2 2024 · Jun 30, 2023 $11.27M
Rd Expense Q2 2024 · Jun 30, 2023 $17.5M
Net Income Q2 2024 · Jun 30, 2023 −$8.74M
Net Income Q2 2024 · Jun 30, 2023 −$12.56M
Operating Income Q2 2024 · Jun 30, 2023 −$13.26M
Operating Income Q2 2024 · Jun 30, 2023 −$20.4M